A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events

Keyphrases

• Hypoxia 100%
• Annexin A2 (ANXA2) 100%
• Angiogenic 100%
• Annexin 100%
• Hexapeptide 100%
• Tissue Plasminogen Activator (t-PA) 50%
• Neovascularization 37%
• Angiogenesis 25%
• Plasmin 25%
• Hypoxic Condition 25%
• Therapeutic Strategies 12%
• Binding Site 12%
• Murine Model 12%
• Endothelial Cells 12%
• Cell Surface 12%
• New Blood Vessel 12%
• In Vivo Model 12%
• Extracellular Proteolysis 12%
• Human Retinal Endothelial Cells 12%
• Angiogenic Response 12%
• Cell Surface Receptor 12%
• Vascular Sprouting 12%
• Plasmin Generation 12%
• Antiproteolytic 12%
• Neovascular 12%
• Competitive Inhibitor 12%
• Disease-associated 12%
• Regulatory Molecules 12%

Biochemistry, Genetics and Molecular Biology

• Annexin 100%
• Annexin A2 100%
• Tissue Plasminogen Activator 66%
• Plasmin 50%
• Neovascularization (Pathology) 50%
• Fibrinolysin 50%
• Angiogenesis 33%
• Binding Site 16%
• Surface Property 16%
• N-Terminus 16%
• Competitive Inhibition 16%
• Protein Catabolism 16%
• Sprouting Angiogenesis 16%
• Cell Surface Receptor 16%

Neuroscience

• Lipocortin 2 100%
• Annexin 100%
• Hexapeptide 100%
• Tissue Plasminogen Activator 66%
• Fibrinolysin 50%
• Angiogenesis 33%
• Binding Site 16%
• In Vivo 16%
• Amino Terminal Sequence 16%
• Cell Surface Receptor 16%
• Proteolysis 16%
• Competitive Inhibition 16%